Health Canada — Medical Devices · Canada · 2014-01-06 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Baxter has provided customers with an important product information notice regarding floseal hemostatic matrix. An update has been added to the precautionary statement of the instructions for use reminding users of the potential risk of inadvertent intravascular uptake of flowable hemostatic material, particularly during surgical procedures which require exposure and opening of large or multiple veins (Venous Plexi). This may result in life-threatening thromboembolic events, either at the time of application or in the post-operative period. Patient positioning during surgery can result in low or negative venous pressure, leading to hemostat introduction into the patient's blood stream.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.